Gemalto-owned Cinterion has inked a deal with TZ Medical to embed a cellular wireless chip into the medical device company's heart arrhythmia monitoring device, Aera-CT, which the companies expect to launch in North America during the third quarter. TZ explains that the device can monitor patients for up to 28 days and also enables care providers to communicate with patients via the device.
The...
